These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8797176)

  • 1. Alteration of cyclosporin-A pharmacokinetics after experimental spinal cord injury.
    Ibarra A; Guízar-Sahagún G; Correa D; Kretschmer R; Grijalva I; Flores-Murrieta FJ; Castañeda-Hernández G; Odor A; López RM; Franco-Bourland R; Espitia AL; Salgado-Ceballos H; Madrazo I
    J Neurotrauma; 1996 May; 13(5):267-72. PubMed ID: 8797176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of cyclosporin-A in experimental spinal cord injury: design of a dosing strategy to maintain therapeutic levels.
    Ibarra A; Reyes J; Martínez S; Correa D; Guízar-Sahagún G; Grijalva I; Castañeda-Hernández G; Flores-Murrieta FJ; Franco-Bourland R; Madrazo I
    J Neurotrauma; 1996 Oct; 13(10):569-72. PubMed ID: 8915908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of factors to decrease bioavailability of cyclosporin A in rats with gentamicin-induced acute renal failure.
    Shibata N; Inoue Y; Fukumoto K; Nishimura A; Fukushima K; Yoshikawa Y; Spiteller G; Takada K
    Biol Pharm Bull; 2004 Mar; 27(3):384-91. PubMed ID: 14993807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of tetramethylpyrazine on the pharmacokinetics of intragastrically administered cyclosporine A in rats].
    Liu XL; Tang J; Song J; He J; Xu P; Peng WX
    Yao Xue Xue Bao; 2006 Sep; 41(9):882-7. PubMed ID: 17111838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased cyclosporine bioavailability induced by experimental nephrotic syndrome in rats.
    Medeiros M; Pérez-Urizar J; Pedraza-Chaverri J; Muñoz-Arizpe R; Castañeda-Hernández G
    Can J Physiol Pharmacol; 2007 May; 85(5):502-6. PubMed ID: 17632584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of tauroursodeoxycholate solutions on cyclosporin A bioavailability in rats.
    Balandraud-Pieri N; Queneau PE; Caroli-Bosc FX; Bertault-Pérès P; Montet AM; Durand A; Montet JC
    Drug Metab Dispos; 1997 Aug; 25(8):912-6. PubMed ID: 9280397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute, subacute and chronic effect of cyclosporin-A on mean arterial pressure of rats with severe spinal cord contusion.
    Romero SE; Bravo G; Hong E; Rojas G; Ibarra A
    Neurosci Lett; 2008 Nov; 445(1):99-102. PubMed ID: 18775474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interaction of the diltiazem with oral and intravenous cyclosporine in rats.
    Kalkan S; Gumustekin M; Aygoren O; Tuncok Y; Gelal A; Guven H
    Eur J Drug Metab Pharmacokinet; 2004; 29(2):119-23. PubMed ID: 15230340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclosporin-A inhibits lipid peroxidation after spinal cord injury in rats.
    Diaz-Ruiz A; Rios C; Duarte I; Correa D; Guizar-Sahagun G; Grijalva I; Ibarra A
    Neurosci Lett; 1999 Apr; 266(1):61-4. PubMed ID: 10336184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of two oral cyclosporin a formulations in clinically stable heart-transplant patients.
    Baraldo M; Pea F; Poz D; Furlanut M
    Pharmacol Res; 2001 Jun; 43(6):547-51. PubMed ID: 11419964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concurrent administration of water-soluble vitamin E can increase the oral bioavailability of cyclosporine a in healthy dogs.
    Fischer JR; Harkin KR; Freeman LC
    Vet Ther; 2002; 3(4):465-73. PubMed ID: 12584684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of multiple oral dosing of itraconazole on the pharmacokinetics of cyclosporine in cats.
    Katayama M; Katayama R; Kamishina H
    J Feline Med Surg; 2010 Jun; 12(6):512-4. PubMed ID: 20371199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of purple grape juice in cyclosporine bioavailability.
    Oliveira-Freitas VL; Dalla Costa T; Manfro RC; Cruz LB; Schwartsmann G
    J Ren Nutr; 2010 Sep; 20(5):309-13. PubMed ID: 20303792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential adverse effects of cyclosporin A on kidneys after spinal cord injury.
    Lonjon N; Boniface G; Feifel R; Endres R; Gimenez y Ribotta M; Privat A; Perrin FE
    Spinal Cord; 2011 Mar; 49(3):472-9. PubMed ID: 20838405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the six-mer synthetic peptide (AT1002) fragment of zonula occludens toxin on the intestinal absorption of cyclosporin A.
    Song KH; Fasano A; Eddington ND
    Int J Pharm; 2008 Mar; 351(1-2):8-14. PubMed ID: 17954018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Wuzhi tablet (Schisandra sphenanthera extract) on the pharmacokinetics of cyclosporin A in rats.
    Xue XP; Qin XL; Xu C; Zhong GP; Wang Y; Huang M; Bi HC
    Phytother Res; 2013 Aug; 27(8):1255-9. PubMed ID: 22996305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of gastrointestinal inflammation and age on the pharmacokinetics of oral microemulsion cyclosporin A in the first month after bone marrow transplantation.
    Schultz KR; Nevill TJ; Balshaw RF; Toze CL; Corr T; Currie CJ; Strong DK; Keown PA
    Bone Marrow Transplant; 2000 Sep; 26(5):545-51. PubMed ID: 11019845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic behavior of cyclosporin A in rabbits by oral administration of lecithin vesicle and Sandimmun Neoral.
    Guo J; Ping Q; Chen Y
    Int J Pharm; 2001 Mar; 216(1-2):17-21. PubMed ID: 11274802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of multiple oral dosing of fluconazole on the pharmacokinetics of cyclosporine in healthy beagles.
    Katayama M; Igarashi H; Tani K; Nezu Y; Harada Y; Yogo T; Hara Y; Aoki S; Tagawa M
    J Vet Med Sci; 2008 Jan; 70(1):85-8. PubMed ID: 18250577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of cyclosporine A bioavailability by incorporating ethyl docosahexaenoate in the microemulsion as an oil excipient.
    Hirunpanich V; Sato H
    Eur J Pharm Biopharm; 2009 Oct; 73(2):247-52. PubMed ID: 19560537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.